Photo by Bo Jungmayer/Used with permission by FHCRC. People in Seattle are going to be reading a lot more about t-cells as the roll-out continues for Juno Therapeutics, one of the biggest launches of a new biotech company in history. Juno aims to harness the body’s own immune system cells, known as t-cells, to fight … Continue reading Juno sharpens Seattle “immune” focus
Read the full article in Seattle Business, May 2011. With a billion-dollar partner excited about early promise for yeast-grown antibodies, Alder Biopharmaceuticals is striding carefully toward the commercial launch of what may be a major rheumatoid arthritis drug.